ALOX15 and colitis: In other words, in DSS colitis the first effect of our genetic manipulation (prevention of endogenous leukotriene biosynthesis) is likely to induce less severe colitis symptoms but this protective effect might be compensated by the augmented formation of Alox15 products by the mutant enzyme.